Q2 EPS Estimate for Acadia Healthcare Reduced by Analyst

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Analysts at Zacks Research cut their Q2 2026 earnings per share estimates for shares of Acadia Healthcare in a research note issued on Wednesday, May 13th. Zacks Research analyst Team now anticipates that the company will earn $0.35 per share for the quarter, down from their previous estimate of $0.49. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $1.49 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q3 2026 earnings at $0.49 EPS, FY2026 earnings at $1.46 EPS, Q1 2028 earnings at $0.24 EPS and FY2028 earnings at $1.76 EPS.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The firm had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same quarter in the prior year, the company earned $0.40 EPS. The business’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS.

Several other brokerages have also issued reports on ACHC. UBS Group increased their target price on Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a research report on Friday, April 17th. Jefferies Financial Group reiterated a “hold” rating and set a $24.50 price objective on shares of Acadia Healthcare in a research note on Monday, April 20th. TD Cowen lifted their price objective on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. Barclays lifted their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. Finally, Royal Bank Of Canada lifted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $26.04.

Acadia Healthcare Stock Up 4.3%

Shares of NASDAQ:ACHC opened at $27.15 on Thursday. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $30.20. The firm has a market capitalization of $2.50 billion, a P/E ratio of -2.22, a P/E/G ratio of 8.73 and a beta of 0.73. The stock has a 50 day moving average price of $25.17 and a 200-day moving average price of $19.19. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC increased its holdings in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares in the last quarter. Bayforest Capital Ltd bought a new stake in shares of Acadia Healthcare in the 4th quarter worth $52,000. Hantz Financial Services Inc. increased its holdings in shares of Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.